Measurement of Crostin serum level after administration of Crocina tablet using HPLC technique
Phase 2
Recruiting
- Conditions
- Evaluation of the concentration-time curve of the a Crostin in healthy people.
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 5
Inclusion Criteria
Patient willingness to participate in the study
Age above 18 years
No addiction to narcotics, sedatives and alcohol
No history of mental illness, no use of anticoagulants
Absence of diabetes
Absence of underlying disease
Exclusion Criteria
Hemodynamic instability in participant
history of Cardiopulmonary resuscitation in participant
past medical history of admission in the intensive care unit
abnormal liver tests ( AST? ALT? CBC )
abnormal kidney tests ( U/A? BUN? Cr )
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of crostin blood concentration. Timepoint: Blood sampling will be done at 0, 30, 60, 90, 120, 180 and 240 minutes after drug administration. Method of measurement: Determination of crostin blood concentration by HPLC (High-performance liquid chromatography) system.
- Secondary Outcome Measures
Name Time Method